Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study

• Main Authors: Chen B (Author), Zhang L (Author), Cheng J (Author), Wu T (Author), Lei J (Author), Yang X (Author), Zhang R (Author), Safadi R (Author), Li Y (Author), Si T (Author), Lu Y (Author)
• Format: Book
• Published: Dove Medical Press, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bowen Chen,1,2,* Linzhi Zhang,2,3,* Jiamin Cheng,2,* Tong Wu,2 Jin Lei,2,4 Xu Yang,5 Rongling Zhang,6 Rifaat Safadi,7 Yinyin Li,2 Tongguo Si,3 Yinying Lu1,2,8,9 1Peking University 302 Clinical Medical School, Beijing, People's Republic of China; 2Senior Department of Hep...